Skip to content
Recall Observatory FDA recall evidence

Drug product

Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56

D-1334-2022

July 22, 2022

Class III

Product summary

Firm
Teva Pharmaceuticals USA Inc
Event
Event 90594
Status
Terminated
Classification
Class III
Quantity
4162 cartons
Official record key
drug-enforcement:D-1334-2022

Official wording

Reason: Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.

Code information: Lot: FE22001A, Exp 01/2024

Distribution pattern: Distributed in Ohio

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent